The Huffington Post profiles Philippe Douste-Blazy, U.N. under-secretary-general of Innovative Financing for Development and chair of UNITAID, a financing mechanism he conceived in 2004 to help provide medicines for HIV, tuberculosis and malaria in developing countries. The article discusses Douste-Blazy’s work and background, UNITAID, and other innovative financing schemes (Lines, 10/6).
Private Sector Involvement
The Huffington Post, as part of a collaboration on trade issues with the Dylan Ratigan Show, examines how “a new trade deal the Obama administration is pushing to complete with Vietnam and seven other Pacific nations threatens to seriously hinder both U.S. and international efforts to combat AIDS — including the government’s own efforts in Vietnam.” Under the Trans-Pacific Partnership, “U.S. negotiators are seeking to impose a set of restrictive intellectual property laws that would help American drug companies secure long-term monopolies overseas,” according to leaked documents, the Huffington Post writes.
In a special report, CNBC.com examines “the world of counterfeit pharmaceuticals, from the dangers they pose and where they’re made, to what is being done to combat them.” The news service notes that “[i]n some countries, counterfeit prescription drugs comprise as much as 70 percent of the drug supply and have been responsible for thousands of deaths in some of the world’s most impoverished nations, according to the World Health Organization (WHO),” and adds that counterfeit drugs also affect people in developed nations (Toscano, 10/4).
In this post in the Guardian’s “Sustainable Business Blog,” Mark Kramer, founder and managing director of the non-profit consulting firm FSG and senior fellow at the CSR Initiative at the Harvard Kennedy School of Government, examines how “[g]lobal corporations are increasingly finding ways to create shared value — pursuing business initiatives that improve social and environmental conditions while earning the company a profit and conferring a competitive advantage.”
“The global health community has come to appreciate the potential of mHealth,” but the technology’s use for health programs in developing countries “remains in its infancy, with many of the characteristics and issues typical of young industries,” Amanda Glassman of the Center for Global Development (CGD) and Vicky Hausman of Dalberg Global Development…
In this post on the PLoS “Speaking of Medicine” blog, Madhukar Pai, a professor and tuberculosis (TB) researcher based at McGill University, co-chair of the Stop TB Partnership’s New Diagnostics Working Group, and a consultant to the Bill & Melinda Gates Foundation, describes a recent conference on TB diagnostics at…
New York Times 'Small Fixes' Section Examines Multiple Low-Cost Interventions For Global Health Problems
The New York Times on Monday published a special section, titled “Small Fixes,” containing several articles examining how low-cost innovations could help save thousands of lives. The articles examine issues as diverse as using circumcision to reduce the risk of HIV infection among men to a water-filtering straw that can provide one person with clean drinking water for up to one year. Other articles examine paper diagnostic tests for liver damage, using vinegar to diagnose precancerous cervical lesions, nectar poisons to kill disease-carrying mosquitos, a wetsuit-like compression suit that can save a woman experiencing hemorrhaging after giving birth, and scratch-off labels on medicines that allow a user to text message a code and discover whether the drugs are counterfeit, among others (Various authors, 9/26).
The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports. “Wealthy nations donated $4.3 billion to purchase the vaccines as part of a plan to immunize 250 million children by 2015,” the news service notes (Bennett, 9/27).
The San Francisco Chronicle reports on a growing interest in global health throughout the U.S. and how Jaime Sepulveda, who served as head of epidemiology in Mexico in the early 1980s and who took over the Global Health Sciences division at the University of California, San Francisco (UCSF) earlier this month, “hopes to make the Bay Area a powerhouse in research and development of global health policies worldwide.” The newspaper writes, “In the past five years, global health has taken off at the Bay Area’s top research institutions,” adding, “Both UCSF and Stanford have opened new global health centers, and Kaiser Permanente — the Bay Area’s largest health care provider — has formalized a program to send its doctors and nurses overseas.”
USAID, the Aspen Institute, the Rockefeller Foundation, IBM, Hyatt Hotels and many other private sector donors on Thursday announced a commitment of more than $3.5 million “to provide assistance to address the challenges of the disabled in Vietnam, without regard to cause,” according to an Aspen Institute press release. The program,…